COIMBRA, Portugal, June 26, 2017 /PRNewswire/ -- At the
16th International Photodynamic Association (IPA) World
Congress in Coimbra, Dr. David
Kessel was the recipient of the 2017 LIFETIME ACHIEVEMENT
AWARD IN PDT BASIC RESEARCH.
Logo -
http://mma.prnewswire.com/media/527945/International_Photodynamic_Association_Logo.jpg
David Kessel, Ph.D., Professor,
Department of Pharmacology at the Wayne State
University School of Medicine (Detroit, Michigan) has been a pioneering
leader in the field of basic PDT research for over 40 years. His
most significant research achievements include the development and
characterization of photosensitizers, elucidating cellular
mechanisms of PDT response with crucial contributions in the
understanding of apoptosis induction and the role of autophagy in
PDT-treated cells. Dr. Kessel's research relating to
photosensitization and drug resistance has been supported by the
National Institutes of Health and the American Cancer Society. He
is the author of more than 350 papers and has edited seven books.
Aside from his extensive research, Dr. Kessel has made enormous
contributions to the advancement of the PDT field as past IPA
President, conference organizer, keynote speaker, journal editor,
reviewer, mentor and author of key review articles.
The Coimbra World Congress was the 16th conference
held by the International Photodynamic Association, marking 32
years of this global meeting. The IPA World Congresses, held every
two years, are the leading PDT meetings bringing together members
of the global photodynamic community in order to advance scientific
and clinical research relating to photodiagnosis and photodynamic
therapies. The next IPA World Congress is to be hosted in
Boston, USA and will be led by Dr. Tayyaba Hasan, Professor of Dermatology at the
Wellman Center for Photomedicine, Harvard
Medical School (HMS) and a Professor of Health Sciences and
Technology (Harvard-MIT).
About Photodynamic Therapy (PDT)
Photodynamic Therapy (PDT) is a combination therapy involving
light activated photosensitizers to diagnose and treat various
types of cancers and pre-cancers, macular degeneration and
multidrug resistant biofilm infections involving bacteria, viruses
and fungi.
CONTACT: www.internationalphotodynamic.com |
info@photodynamic.org